#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    NTRK gene fusion overexpression Marginal zone lymphoma recurrent Peritoneal mesothelioma malignant Metastatic malignant melanoma Waldenstrom's macroglobulinaemia Anti-myelin-associated glycoprotein antibodies positive Inborn error of metabolism Neonatal alloimmune thrombocytopenia Ewing's sarcoma recurrent Plasma cell myeloma recurrent Proteus syndrome Inclusion body myositis Diffuse large B-cell lymphoma refractory Malignant peritoneal neoplasm Cystic fibrosis respiratory infection suppression More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Trials in Disease Aicardi-Goutieres syndrome – Basic Information Mastocytosis – Basic Information Loeys-Dietz syndrome – Basic Information Alveolar rhabdomyosarcoma Familial amyotrophic lateral sclerosis – Life with Disease Hereditary motor and sensory neuropathy Progressive multifocal leukoencephalopathy – Diagnostics Vascular malformation – Basic Information Primary biliary cholangitis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Plasma Protein Epinephrine Hydrochloride Midodrine Hydrochloride Trazodone Lovo-B Ramipril Benzylpenicillin Thiamine Nitrate Ecoo1A Pentetic Acid Mps-103 Ralinepag Sar-443579 Hydrocortisone Ph. Eur. Afamitresgene Autoleucel Dazodalibep Idecabtagene Vicleucel Inavolisib Glycopyrronium Bromide Pitolisant More therapies…

    Learn about Your Condition

    Colon cancer stage IV Herpes zoster Pulmonary tuberculosis Tumour of ampulla of Vater Thrombosis Partial lipodystrophy Vestibular disorder Pericarditis Dyskinesia Medulloblastoma recurrent Skin wrinkling Arterial disorder Cervix carcinoma stage III Retinal artery occlusion Electronic cigarette user More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. KBC Zagreb

KBC Zagreb

Ulica Mije Kispatica 12, Zagreb, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of (+)-α-Dihydrotetrabenazine for Treating Tardive Dyskinesia in Patients with Schizophrenia, Mood, or Gastrointestinal Disorders

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Tardive dyskinesia
    Investigated Drugs:
    • (2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol
    Croatia

  • Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Estonia France +12

  • Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • Chloropyramine Hydrochloride
    • Chlorphenamine Maleate
    • Dexchlorpheniramine Maleate
    Austria Croatia Denmark France Germany Greece +6

  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Factor VIII deficiency
    Investigated Drugs:
    • Efmoroctocog Alfa
    • Eftrenonacog Alfa
    Bulgaria Croatia Czechia France Hungary Ireland +4

  • Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Lenvatinib
    • Atezolizumab
    Austria Belgium Bulgaria Croatia Estonia Finland +6

  • A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Austria Belgium Bulgaria Croatia Czechia France +8

  • Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

    Not recruiting

    3 1
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

    Not recruiting

    3 1
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Goserelin
    • Triptorelin
    • Leuprorelin Acetate
    Austria Belgium Bulgaria Croatia Czechia Estonia +10
Previous Page
1 … 5 6 7 8 9 … 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!